Article Versions Notes

Liu W-T, Lin C, Tsai M-C, Cheng C-C, Chen S-J, Liou J-T, Lin W-S, Cheng S-M, Lin C-S, Tsao T-P. Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on the Risk of New-Onset Diabetes Mellitus: A Single-Center Cohort Study. Biomedicines. 2020; 8(11):499. https://doi.org/10.3390/biomedicines8110499

Liu, Wei-Ting, Chin Lin, Min-Chien Tsai, Cheng-Chung Cheng, Sy-Jou Chen, Jun-Ting Liou, Wei-Shiang Lin, Shu-Meng Cheng, Chin-Sheng Lin, and Tien-Ping Tsao. 2020. "Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on the Risk of New-Onset Diabetes Mellitus: A Single-Center Cohort Study" Biomedicines 8, no. 11: 499. https://doi.org/10.3390/biomedicines8110499

Liu, W.-T., Lin, C., Tsai, M.-C., Cheng, C.-C., Chen, S.-J., Liou, J.-T., Lin, W.-S., Cheng, S.-M., Lin, C.-S., & Tsao, T.-P. (2020). Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on the Risk of New-Onset Diabetes Mellitus: A Single-Center Cohort Study. Biomedicines, 8(11), 499. https://doi.org/10.3390/biomedicines8110499